283 related articles for article (PubMed ID: 31231387)
21. Stromal cell-derived factor-1alpha-directed chemoattraction of transiently CXCR4-overexpressing bone marrow stromal cells into functionalized three-dimensional biomimetic scaffolds.
Thieme S; Ryser M; Gentsch M; Navratiel K; Brenner S; Stiehler M; Rölfing J; Gelinsky M; Rösen-Wolff A
Tissue Eng Part C Methods; 2009 Dec; 15(4):687-96. PubMed ID: 19260802
[TBL] [Abstract][Full Text] [Related]
22. Dextran sulfate and stromal cell derived factor-1 promote CXCR4 expression and improve bone marrow homing efficiency of infused hematopoietic stem cells.
Hayakawa J; Migita M; Ueda T; Fukazawa R; Adachi K; Ooue Y; Hayakawa M; Shimada T; Fukunaga Y
J Nippon Med Sch; 2009 Aug; 76(4):198-208. PubMed ID: 19755795
[TBL] [Abstract][Full Text] [Related]
23. Flt3-ligand-mobilized peripheral blood, but not Flt3-ligand-expanded bone marrow, facilitating cells promote establishment of chimerism and tolerance.
Huang Y; Kucia M; Rezzoug F; Ratajczak J; Tanner MK; Ratajczak MZ; Schanie CL; Xu H; Fugier-Vivier I; Ildstad ST
Stem Cells; 2006 Apr; 24(4):936-48. PubMed ID: 16644924
[TBL] [Abstract][Full Text] [Related]
24. Engineering lymph node homing of ex vivo-expanded human natural killer cells via trogocytosis of the chemokine receptor CCR7.
Somanchi SS; Somanchi A; Cooper LJ; Lee DA
Blood; 2012 May; 119(22):5164-72. PubMed ID: 22498742
[TBL] [Abstract][Full Text] [Related]
25.
Sato N; Stringaris K; Davidson-Moncada JK; Reger R; Adler SS; Dunbar C; Choyke PL; Childs RW
Clin Cancer Res; 2020 Jun; 26(11):2573-2581. PubMed ID: 32034075
[TBL] [Abstract][Full Text] [Related]
26. An Uncoupling of Canonical Phenotypic Markers and Functional Potency of
Lieberman NAP; DeGolier K; Haberthur K; Chinn H; Moyes KW; Bouchlaka MN; Walker KL; Capitini CM; Crane CA
Front Immunol; 2018; 9():150. PubMed ID: 29456538
[TBL] [Abstract][Full Text] [Related]
27. Highly Efficient Generation of Transgenically Augmented CAR NK Cells Overexpressing CXCR4.
Jamali A; Hadjati J; Madjd Z; Mirzaei HR; Thalheimer FB; Agarwal S; Bonig H; Ullrich E; Hartmann J
Front Immunol; 2020; 11():2028. PubMed ID: 32983147
[TBL] [Abstract][Full Text] [Related]
28. Real-Time Tracking of
Uong TNT; Lee KH; Ahn SJ; Kim KW; Min JJ; Hyun H; Yoon MS
Front Immunol; 2018; 9():825. PubMed ID: 29770131
[TBL] [Abstract][Full Text] [Related]
29. Mesenchymal Stem/Stromal Cells Overexpressing CXCR4
Bidkhori HR; Bahrami AR; Farshchian M; Heirani-Tabasi A; Mirahmadi M; Hasanzadeh H; Ahmadiankia N; Faridhosseini R; Dastpak M; Shabgah AG; Matin MM
Cell Transplant; 2021; 30():9636897211054498. PubMed ID: 34807749
[TBL] [Abstract][Full Text] [Related]
30. RNA-Seq Analysis Reveals CCR5 as a Key Target for CRISPR Gene Editing to Regulate In Vivo NK Cell Trafficking.
Levy ER; Clara JA; Reger RN; Allan DSJ; Childs RW
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33669611
[TBL] [Abstract][Full Text] [Related]
31. Decitabine enhances targeting of AML cells by CD34
Cany J; Roeven MWH; Hoogstad-van Evert JS; Hobo W; Maas F; Franco Fernandez R; Blijlevens NMA; van der Velden WJ; Huls G; Jansen JH; Schaap NPM; Dolstra H
Blood; 2018 Jan; 131(2):202-214. PubMed ID: 29138222
[TBL] [Abstract][Full Text] [Related]
32. Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours.
Shenouda MM; Gillgrass A; Nham T; Hogg R; Lee AJ; Chew MV; Shafaei M; Aarts C; Lee DA; Hassell J; Bane A; Dhesy-Thind S; Ashkar AA
Breast Cancer Res; 2017 Jul; 19(1):76. PubMed ID: 28668076
[TBL] [Abstract][Full Text] [Related]
33. A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma.
Geminder H; Sagi-Assif O; Goldberg L; Meshel T; Rechavi G; Witz IP; Ben-Baruch A
J Immunol; 2001 Oct; 167(8):4747-57. PubMed ID: 11591806
[TBL] [Abstract][Full Text] [Related]
34. Characterization of a new WHIM syndrome mutant reveals mechanistic differences in regulation of the chemokine receptor CXCR4.
Luo J; De Pascali F; Richmond GW; Khojah AM; Benovic JL
J Biol Chem; 2022 Feb; 298(2):101551. PubMed ID: 34973340
[TBL] [Abstract][Full Text] [Related]
35. Stem cell plasticity revisited: CXCR4-positive cells expressing mRNA for early muscle, liver and neural cells 'hide out' in the bone marrow.
Ratajczak MZ; Kucia M; Reca R; Majka M; Janowska-Wieczorek A; Ratajczak J
Leukemia; 2004 Jan; 18(1):29-40. PubMed ID: 14586476
[TBL] [Abstract][Full Text] [Related]
36. Enhanced function with decreased internalization of carboxy-terminus truncated CXCR4 responsible for WHIM syndrome.
Kawai T; Choi U; Whiting-Theobald NL; Linton GF; Brenner S; Sechler JM; Murphy PM; Malech HL
Exp Hematol; 2005 Apr; 33(4):460-8. PubMed ID: 15781337
[TBL] [Abstract][Full Text] [Related]
37. Multiple Myeloma Impairs Bone Marrow Localization of Effector Natural Killer Cells by Altering the Chemokine Microenvironment.
Ponzetta A; Benigni G; Antonangeli F; Sciumè G; Sanseviero E; Zingoni A; Ricciardi MR; Petrucci MT; Santoni A; Bernardini G
Cancer Res; 2015 Nov; 75(22):4766-77. PubMed ID: 26438594
[TBL] [Abstract][Full Text] [Related]
38. Natural Killer Cell Homing and Persistence in the Bone Marrow After Adoptive Immunotherapy Correlates With Better Leukemia Control.
Grzywacz B; Moench L; McKenna D; Tessier KM; Bachanova V; Cooley S; Miller JS; Courville EL
J Immunother; 2019; 42(2):65-72. PubMed ID: 30489431
[TBL] [Abstract][Full Text] [Related]
39. WHIM syndrome caused by a single amino acid substitution in the carboxy-tail of chemokine receptor CXCR4.
Liu Q; Chen H; Ojode T; Gao X; Anaya-O'Brien S; Turner NA; Ulrick J; DeCastro R; Kelly C; Cardones AR; Gold SH; Hwang EI; Wechsler DS; Malech HL; Murphy PM; McDermott DH
Blood; 2012 Jul; 120(1):181-9. PubMed ID: 22596258
[TBL] [Abstract][Full Text] [Related]
40. Combined IL-15 and IL-12 drives the generation of CD34
Cany J; van der Waart AB; Spanholtz J; Tordoir M; Jansen JH; van der Voort R; Schaap NM; Dolstra H
Oncoimmunology; 2015 Jul; 4(7):e1017701. PubMed ID: 26140247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
